[112] Treatment with melatonin (20 mg/day) was also associated with greater one-year survival than supportive care alone in patients with brain metastases
Our website is designed to be a comprehensive resource, offering detailed product information and support
With the right supplement and consistent use, a healthier, long-lasting glow becomes completely achievable
Pictured: Woman grasping her stomach in pain/iStock, Doucefleur The use of glucagon-like peptide 1 (GLP-1) agonists for weight loss, such as Novo Nordisks Ozempic and Wegovy, is associated with the risk of gastrointestinal adverse events, according to a study published Thursday in the medical journal JAMA
Grabrucker S, Marizzoni M, Silajdi E, Lopizzo N, Mombelli E, Nicolas S, et al
Choosing the right medication depends on your: Health history Weight loss goals Insurance coverage Lifestyle Our physicians will guide you in selecting the safest and most effective treatment plan